Alas, federal funding for the exemplary Drug and Therapeutics Information Service ended on the last day of June.

I am devastated, as I know other colleagues of mine are.

I value academic excellence made accessible to frontline GPs.

I value the opportunity to have interactions with a truly devoted team of experts on the quality use of medicines who have refined their skills over decades.